Biological basis of schizophrenic disorders
著者
書誌事項
Biological basis of schizophrenic disorders
（Taniguchi symposia on brain sciences, no. 14）
Japan Scientific Societies Press , Karger, c1991
- : ja
- : sz
大学図書館所蔵 件 / 全11件
-
該当する所蔵館はありません
- すべての絞り込み条件を解除する
注記
"14th International Symposium on the Biological Basis of Schizophrenic Disorders held September 5-8, 1990, in Katata, Japan under the sponsorship of the Taniguchi Foundation"--Pref.
Includes bibliographical references and indexes
内容説明・目次
内容説明
Despite significant achievements in the biological study of schizophrenia, various characteristics of the disorder still need to be explained. This volume brings together the latest findings and expertise of internationally acknowledged experts in biological research on schizophrenia. The contributors detail recent advances in approaches to the disorder, ranging from the application of event-related potential as a psychophysiological means of analyzing schizophrenia as a perception defect to brain imaging and genetic linkage studies. The collection of papers offers a new direction for exploration into possible cures for schizophrenic patients and will be of interest to those concerned with the disorder.
目次
- Part 1 Psychophysiology - event-related potentials and eye movement: information processing deficits and event-related potentials in schizophrenia
- longitudinal studies of clinial and ERP correlates of thought disorder and positive/negative symptoms in schizophrenia
- schizophrenia and eye movement
- mid-latency auditory evoked responses and neuroimaging in schizophrenia. Part 2 Brain chemistry - postmortem neurochemistry and signal transduction: the neurochemical pathology of schizophrenia - evidence for abnormalities in amino acid transmitter systems
- dysfunction of excitatory amino acidergic systems and schizophrenic disorders
- protein phosphorylation in the nervous system - possible relevance to schizophrenia research
- neurochemical abnormalities in chronic schizophrenia. Part 3 Psychopharmacology - basic and clinic: neuropeptide abnormalities in schizophrenia
- receptor mechanisms in schizophrenia
- possible role for the sigma receptor
- effects of chronic neuroleptic treatment on neurotransmitter receptors and tardive dyskinesia
- plasma homovanillic acid, serum anti-D1 and anti-D2 receptor activity and psychopathology in schizophrenia. Part 4 Amphetamine psychosis: methamphetamine psychosis as a model of relapse of schizophrenia: a behavioural and biochemical study in the animal model
- the neurobiology of amphetamine psychosis - evidence from studies with an animal model
- changes in dopaminergic and dopaminoceptive functions of the rat brain after repeated administration of methamphetamine. Part 5 Brain imaging and genetic linkage studies: positron emission tomography study of phencyclidine users as a possible drug model of schizophrenia
- spect analysis of auditory hallucination and neuroleptic effects on regional brain function in schizophrenia
- molecular genetics in schizophrenia.
「Nielsen BookData」 より
